Page 518 - Williams Hematology ( PDFDrive )

492 Part VI: The Erythrocyte Chapter 32: Erythropoiesis 493

93. Ebert BL, Bunn HF: Regulation of the erythropoietin gene. Blood 94(6):1864, 1999. 126. Baek JH, Liu YV, McDonald KR, et al: Spermidine/spermine N(1)-acetyltransferase-1
94. Constantinescu SN, Keren T, Socolovsky M, et al: Ligand-independent oligomerization binds to hypoxia-inducible factor-1alpha (HIF-1alpha) and rack1 and promotes ubiq-
of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc uitination and degradation of HIF-1alpha. J Biol Chem 282(46):33358, 2007.
Natl Acad Sci U S A 98(8):4379, 2001. 127. Gruber M, Hu CJ, Johnson RS, et al: Acute postnatal ablation of HIF-2alpha results in
95. Witthuhn BA, Quelle FW, Silvennoinen O, et al: Jak2 associates with the erythropoietin anemia. Proc Natl Acad Sci U S A 104(7):2301, 2007.
receptor and is tyrosine phosphorylated and activated following stimulation with ery- 128. Chavez JC, Baranova O, Lin J, et al: The transcriptional activator hypoxia inducible
thropoietin. Cell 74(2):227, 1993. factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin
96. Damen JE, Wakao H, Miyajima A, et al: Tyrosine 343 in the erythropoietin receptor in cortical astrocytes. J Neurosci 26(37):9471, 2006.
positively regulates erythropoietin-induced cell proliferation and stat5 activation. 129. Sanchez M, Galy B, Muckenthaler MU, et al: Iron-regulatory proteins limit hypoxia-
EMBO J 14(22):5557, 1995. inducible factor-2alpha expression in iron deficiency. Nat Struct Mol Biol 14(5):420,
97. Parganas E, Wang D, Stravopodis D, et al: Jak2 is essential for signaling through a vari- 2007.
ety of cytokine receptors. Cell 93(3):385, 1998. 130. Percy MJ, Furlow PW, Lucas GS, et al: A gain-of-function mutation in the HIF2a gene
98. Divoky V, Prchal JT: Mouse surviving solely on human erythropoietin receptor (EPOR): in familial erythrocytosis. N Engl J Med 358(2):162, 2008.
Model of human EPOR-linked disease. Blood 99(10):3873; author reply 3874, 2002. 131. Liu YV, Baek JH, Zhang H, et al: Rack1 competes with hsp90 for binding to HIF-1alpha
99. Lin CS, Lim SK, D’Agati V, et al: Differential effects of an erythropoietin receptor gene and is required for O(2)-independent and hsp90 inhibitor-induced degradation of
disruption on primitive and definitive erythropoiesis. Genes Dev 10(2):154, 1996. HIF-1alpha. Mol Cell 25(2):207, 2007.
100. D’Andrea AD, Yoshimura A, Youssoufian H, et al: The cytoplasmic region of the ery- 132. Epstein AC, Gleadle JM, McNeill LA, et al: C. Elegans egl-9 and mammalian homo-
thropoietin receptor contains nonoverlapping positive and negative growth-regulatory logs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell
domains. Mol Cell Biol 11(4):1980, 1991. 107(1):43, 2001.
101. Klingmuller U, Lorenz U, Cantley LC, et al: Specific recruitment of sh-ptp1 to the ery- 133. Correa PN, Eskinazi D, Axelrad AA: Circulating erythroid progenitors in polycythemia
thropoietin receptor causes inactivation of jak2 and termination of proliferative signals. vera are hypersensitive to insulin-like growth factor-1 in vitro: Studies in an improved
Cell 80(5):729, 1995. serum-free medium. Blood 83(1):99, 1994.
102. Arcasoy MO, Harris KW, Forget BG: A human erythropoietin receptor gene mutant 134. Mirza AM, Ezzat S, Axelrad AA: Insulin-like growth factor binding protein-1 is ele-
causing familial erythrocytosis is associated with deregulation of the rates of jak2 and vated in patients with polycythemia vera and stimulates erythroid burst formation in
stat5 inactivation. Exp Hematol 27(1):63, 1999. vitro. Blood 89(6):1862, 1997.
103. Marine JC, McKay C, Wang D, et al: Socs3 is essential in the regulation of fetal liver 135. Brox AG, Congote LF, Fafard J, et al: Identification and characterization of an 8-kd
erythropoiesis. Cell 98(5):617, 1999. peptide stimulating late erythropoiesis. Exp Hematol 17(7):769, 1989.
104. Sasaki A, Yasukawa H, Shouda T, et al: Cis3/socs-3 suppresses erythropoietin (EPO) 136. Kent G, Minick OT, Volini FI, et al: Autophagic vacuoles in human red cells. Am J
signaling by binding the EPO receptor and jak2. J Biol Chem 275(38):29338, 2000. Pathol 48(5):831, 1966.
105. Prchal JT, Gregg XT: Erythropoiesis. Genetic abnormalities, in Erythropoietins and Ery- 137. Heynen MJ, Tricot G, Verwilghen RL: Autophagy of mitochondria in rat bone marrow
thropoiesis, edited by G Molineux, MA Foote, and SG Elliot, p 61. Birkhäuser-Verlag erythroid cells. Relation to nuclear extrusion. Cell Tissue Res 239(1):235, 1985.
AG, Basel, 2009. 138. Sandoval H, Thiagarajan P, Dasgupta SK, et al: Essential role for nix in autophagic mat-
106. Roberts KG, Morin RD, Zhang J, et al: Genetic alterations activating kinase and cytok- uration of erythroid cells. Nature 454(7201):232, 2008.
ine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 22(2):153, 139. Kundu M, Lindsten T, Yang CY, et al: Ulk1 plays a critical role in the autophagic
2012. clearance of mitochondria and ribosomes during reticulocyte maturation. Blood
107. Walrafen P, Verdier F, Kadri Z, et al: Both proteasomes and lysosomes degrade the acti- 112(4):1493, 2008.
vated erythropoietin receptor. Blood 105(2):600, 2005. 140. Schweers RL, Zhang J, Randall MS, et al: Nix is required for programmed mitochon-
108. Arcasoy MO, Jiang X, Haroon ZA: Expression of erythropoietin receptor splice variants drial clearance during reticulocyte maturation. Proc Natl Acad Sci U S A 104(49):19500,
in human cancer. Biochem Biophys Res Commun 307(4):999, 2003. 2007.
109. Barron C, Migliaccio AR, Migliaccio G, et al: Alternatively spliced mRNAs encoding 141. Hong CI, De NC, Tritsch GL, et al: Synthesis and biological activities of some N4-
soluble isoforms of the erythropoietin receptor in murine cell lines and bone marrow. substituted 4-aminopyrazolo(3,4-d)pyrimidines. J Med Chem 19(4):555, 1976.
Gene 147(2):263, 1994. 142. Eshghi S, Vogelezang MG, Hynes RO, et al: Alpha4beta1 integrin and erythropoietin
110. Nakamura Y, Nakauchi H: A truncated erythropoietin receptor and cell death: A mediate temporally distinct steps in erythropoiesis: Integrins in red cell development.
reanalysis. Science 264(5158):588, 1994. J Cell Biol 177(5):871, 2007.
111. Prchal JT, Semenza GL, Prchal J, et al: Familial polycythemia. Science 268(5219):1831, 143. Bruchova H, Yoon D, Agarwal AM, et al: Regulated expression of microRNAs in nor-
1995. mal and polycythemia vera erythropoiesis. Exp Hematol 35(11):1657, 2007.
112. Noguchi CT, Wang L, Rogers HM, et al: Survival and proliferative roles of erythropoie- 144. Li Y, Bai H, Zhang Z, et al: The up-regulation of mir-199b-5p in erythroid differentia-
tin beyond the erythroid lineage. Expert Rev Mol Med 10:e36, 2008. tion is associated with GATA-1 and NF-E2. Mol Cells 37(3):213, 2014.
113. Anagnostou A, Lee ES, Kessimian N, et al: Erythropoietin has a mitogenic and positive 145. Raghavachari N, Liu P, Barb JJ, et al: Integrated analysis of miRNA and mRNA during
chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 87(15):5978, 1990. differentiation of human cd34+ cells delineates the regulatory roles of microRNA in
114. Arcasoy MO: The non-haematopoietic biological effects of erythropoietin. Br J Haema- hematopoiesis. Exp Hematol 42(1):14, 2014.
tol 141(1):14, 2008. 146. Lee YT, de Vasconcellos JF, Yuan J, et al: Lin28b-mediated expression of fetal hemoglo-
115. Brines M, Cerami A: Discovering erythropoietin’s extra-hematopoietic functions: Biol- bin and production of fetal-like erythrocytes from adult human erythroblasts ex vivo.
ogy and clinical promise. Kidney Int 70(2):246, 2006. Blood 122(6):1034, 2013.
116. Agarwal N, Gordeuk VR, Prchal JT: Are erythropoietin receptors expressed in tumors? 147. Barde I, Rauwel B, Marin-Florez RM, et al: A KRAB/KAP1-miRNA cascade regulates
Facts and fiction—More careful studies are needed. J Clin Oncol 25(13):1813; author erythropoiesis through stage-specific control of mitophagy. Science 340(6130):350,
reply 1815, 2007. 2013.
117. Hardee ME, Cao Y, Fu P, et al: Erythropoietin blockade inhibits the induction of tumor 148. Pearson TC, Botterill CA, Glass UH, et al: Interpretation of measured red cell mass and
angiogenesis and progression. PLoS One 2(6):e549, 2007. plasma volume in males with elevated venous PCV values. Scand J Haematol 33(1):68,
118. Hirota K, Semenza GL: Regulation of angiogenesis by hypoxia-inducible factor 1. Crit 1984.
Rev Oncol Hematol 59(1):15, 2006. 149. Cavill I, Trevett D, Fisher J, et al: The measurement of the total volume of red cells in
119. Yoon D, Pastore YD, Divoky V, et al: Hypoxia-inducible factor-1 deficiency results in man: A non-radioactive approach using biotin. Br J Haematol 70(4):491, 1988.
dysregulated erythropoiesis signaling and iron homeostasis in mouse development. 150. Jones J, Mollison PL: A simple and efficient method of labelling red cells with 99mTc for
J Biol Chem 281(35):25703, 2006. determination of red cell volume. Br J Haematol 38(1):141, 1978.
120. Fukuda R, Zhang H, Kim JW, et al: Hif-1 regulates cytochrome oxidase subunits to 151. Pearson TC, Guthrie DL, Simpson J, et al: Interpretation of measured red cell mass and
optimize efficiency of respiration in hypoxic cells. Cell 129(1):111, 2007. plasma volume in adults: Expert panel on radionuclides of the international council for
121. Beck I, Ramirez S, Weinmann R, et al: Enhancer element at the 3′-flanking region con- standardization in haematology. Br J Haematol 89(4):748, 1995.
trols transcriptional response to hypoxia in the human erythropoietin gene. J Biol Chem 152. Fairbanks VF, Klee GG, Wiseman GA, et al: Measurement of blood volume and red
266(24):15563, 1991. cell mass: Re-examination of 51cr and 125i methods. Blood Cells Mol Dis 22(2):169;
122. Manalo DJ, Rowan A, Lavoie T, et al: Transcriptional regulation of vascular endothelial discussion 186a, 1996.
cell responses to hypoxia by Hif-1. Blood 105(2):659, 2005. 153. Larson RA: Studies of the body hematocrit phenomenon: Dynamic hematocrit of large
123. Maxwell PH, Wiesener MS, Chang GW, et al: The tumour suppressor protein VHL tar- vessel and initial distribution space of albumin and fibrinogen in the whole body. Scand
gets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271, J Clin Lab Invest 22(3):189, 1998.
1999. 154. Button LN, Gibson JG 2nd, Walter CW: Simultaneous determination of the volume of
124. Ivan M, Kondo K, Yang H, et al: Hifalpha targeted for VHL-mediated destruction by red cells and plasma for survival studies of stored blood. Transfusion 5:143, 1965.
proline hydroxylation: Implications for O sensing. Science 292(5516):464, 2001. 155. Recommended methods for measurement of red-cell and plasma volume: International
2
125. Jaakkola P, Mole DR, Tian YM, et al: Targeting of HIF-alpha to the von Hippel-Lindau committee for standardization in haematology. J Nucl Med 21(8):793, 1980.
ubiquitylation complex by O -regulated prolyl hydroxylation. Science 292(5516):468, 156. Hillman RS, Finch CA: Erythropoiesis: Normal and abnormal. Semin Hematol 4(4):327,
2
2001. 1967.

Kaushansky_chapter 32_p0479-0494.indd 493 9/17/15 6:11 PM